1Special concerns for the specific populations with inflammatory bowel disease.IAN Jia-ming, YANG HongCOMMENTARY177-1792Integration of medical and surgical treatment for the complications of Crohn's disease.GUO Zhen, ZHU Wei-mingCOMMENTARY180-1833Azathiopurine therapy for inflammatory bowel disease: the principle of dosage.CAO QianSYMPOSIUM184-1864Timing of switching to operation for ulcerative colitis.KE Jia, WU Xiao-jianSYMPOSIUM187-1895Management of inflammatory bowel disease in the elderly patient.LIU Ai-ling, LYU HongSYMPOSIUM190-1956Strategy of treatment for very-early-onset and pediatric inflammatory bowel disease.HUANG Ying, YE Zi-qingSYMPOSIUM196-1997Management and therapy in patients with inflammatory bowel disease during pregnancy.TAN Bei, QIAN Jia-mingSYMPOSIUM200-2038Consensus on the management of hepatitis B virus infection in women of childbearing age.Chinese Society of HepatologyGUIDELINE AND CONSENSUS204-2089Interpretation of clinical nutrition guideline to inflammatory bowel disease by the European Society for Clinical Nutrition and Metabolism in 2016.QIAO Yu-qi, RAN Zhi-huaGUIDELINE AND CONSENSUS209-21210Analysis of clinical features of patients with inflammatory bowel disease of combined with thrombosis.DONG Xu-yang, LYU Hong, CHEN Xuan-fu, LI Ji, LI Yue, TAN Bei, SHU Hui-jun, ZHANG Hui-min, QIAN Jia-ming, YANG HongORIGINAL CONTRIBUTION213-21611Risk factors of adverse events associated with infliximab treatment for inflammatory bowel disease.LIU Ai-ling, LYU Hong, LI Yue, YANG Hong, QIAN Jia-mingORIGINAL CONTRIBUTION217-22212Efficacy and safety of thalidomide in the treatment of adult refractory ulcerative colitis.SHU Hui-jun, YANG Hong, WANG Zheng, FEI Gui-jun, QIAN Jia-mingORIGINAL CONTRIBUTION223-22613Clinical analysis of the relationship between low serum IgG level and ulcerative colitis.WANG Zheng, ZHENG Wei-yang, LI Ji, TAN Bei, SHU Hui-jun, LYU Hong, LI Yue, QIAN Jia-ming, YANG HongORIGINAL CONTRIBUTION227-23014The effect of surgical complications on the prognosis of patients with ulcerative colitis-related colorectal cancer.SUN Xi-yu, LI Ji, LI Jing-nan, WU BinORIGINAL CONTRIBUTION231-23515Efficacy of leflunomide in the treatment of adults with steroid-dependent nephrotic syndrome.TU Yuan-mao, ZHANG Li-hua, WANG Xia, ZENG Cai-hong, ZHANG Hai-tao, LI Shi-junORIGINAL CONTRIBUTION236-24116Value of determining Th17 and regulatory T cells in the peripheral blood in evaluating patients with systemic lupus erythematosus.HAO Hui-qin, ZHANG Shao-ran, LI Xiao-feng, CHEN Jun-wei, LUO Jing, LYU Zhi-qinORIGINAL CONTRIBUTION242-24417Acute pancreatitis treatment: the recent five-year progress.ZHENG Xi, HE Wen-hua, LYU Nong-huaREVIEW245-25118Research advances in the treatment of early esophageal carcinoma and precancerous lesion by endoscopic submucosal dissection.LIU Yao-jiang, ZHAO Xiao-yanREVIEW252-25519Report of one case of severe infection suspected to be caused by azathoprine in the treatment of inflammatory bowel disease.XU Tian-ming, LI Jing-nan, QIAN Jia-ming, YANG HongCASE REPORT256-25720The effect of improper operation on ulcerative colitis: one case report.GUO Zhen, GONG Jian-feng, GU Li-li, LI Yi, CAO Lei, ZHU Wei-mingCASE REPORT258-259 